Table 7.

Practice related to hospital preparedness for COVID-19

Item	Percentage N = 81(%)
Is your hospital part of the national network to receive COVID-19 patients?
In progress  No  Yes	18 (22.2%) 35 (43.2%) 28 (34.6%)
Does your hospital have an emergency preparedness/management committee for COVID-19?
In progress  No  Yes	21 (25.9%) 7 (8.6%) 53 (65.4%)
Is the pharmacy represented on the emergency preparedness/management committee of the hospital, and has it participated in the development of the hospital plan?
In progress  No  Yes	11 (13.6%) 19 (23.5%) 51 (63.0%)
Is the pharmacist familiar with best practices from other available plans (national, MOPH, and international, WHO and CDC) related to the pharmacy?
In progress  No  Yes	23 (28.4%) 5 (6.2%) 53 (65.4%)
Has the pharmacy participated in the development of a hospital infection control plan for managing hospital patients with COVID-19?
In progress  No  Yes	16 (19.8%) 22 (27.2%) 43 (53.1%)
In the pharmacy plan, has the pharmacy included a section that describes backup for key pharmacy roles?
In progress  No  Yes	23 (28.4%) 25 (30.9%) 33 (40.7%)
Has the pharmacy designated a pharmacy staff member to coordinate education and training on COVID-19?
In progress  No  Yes	21 (25.9%) 45 (55.6%) 15 (18.5%)
Has the pharmacy prepared a plan to educate pharmacy staff on infection control measures, social distancing practices, PPE, prophylaxis, and treatment?
In progress  No  Yes	26 (32.1%) 16 (19.8%) 39 (48.1%)
Does the pharmacy routinely monitor to ensure that pharmacy staff adheres to infection control and social distancing measures?
In progress  No  Yes	23 (28.4%) 10 (12.3%) 48 (59.3%)
Has the pharmacy identified and trained multiple staff members to perform the critical pharmacy activities including administrative, clinical, distribution, and inventory management functions?
In progress  No  Yes	18 (22.2%) 22 (27.2%) 41 (50.6%)
Has the pharmacy estimated the quantities of essential patient care medications, materials and equipment, and PPE that would be needed during the pandemic phase?
In progress  No  Yes	23 (28.4%) 7 (8.6%) 51 (63.0%)
Has the pharmacy made a plan to ensure the availability of essential patient care medications, materials and equipment, and PPE needed during the lockdown?
In progress  No  Yes	25 (30.9%) 5 (6.2%) 51 (63.0%)
Has the pharmacy developed a list of alternative suppliers for essential medications and devices and a strategy to address shortages?
In progress  No  Yes	31 (38.3%) 9 (11.1%) 41 (50.6%)
Has the pharmacy participated in the development of the hospital treatment plan/guidelines/order sets to treat COVID-19 positive patients?
In progress  No  Yes	27 (33.3%) 16 (19.8%) 38 (46.9%)
Has the pharmacy documented critical pharmacy activities and identified essential pharmacy staff needed to perform them?
In progress  No  Yes	26 (32.1%) 21 (25.9%) 34 (42.0%)
Has the pharmacy identified the minimum staffing needs and prioritized critical services based on essential hospital operations?
In progress  No  Yes	18 (22.2%) 13 (16.0%) 50 (61.7%)
Has the pharmacy determined strategies for staffing, including tele-pharmacy, remote work, split shifts, etc.?
In progress  No  Yes	22 (27.2%) 20 (24.7%) 39 (48.1%)
Has the pharmacy participated in hospital planning related to staff absences, employees’ inability to work—including illness, family issues, fear/anxiety?
In progress  No  Yes	20 (24.7%) 24 (29.6%) 37 (45.7%)
Has the pharmacy or the hospital developed guidance for staff monitoring for signs of illness and created mechanisms for reporting both illness and absenteeism?
In progress  No  Yes	23 (28.4%) 8 (9.9%) 50 (61.7%)
Has the pharmacy or hospital developed a return to work post-illness policy for employees?
In progress  No  Yes	19 (23.5%) 30 (37.0%) 32 (39.5%)
Has the department of pharmacy identified points of contact for COVID-19 pandemic planning resources within the hospital?
In progress  No  Yes	23 (28.4%) 25 (30.9%) 33 (40.7%)